Skip to main content
. 2024 Apr 18;15(4):505. doi: 10.3390/genes15040505

Figure 2.

Figure 2

Results of the decision curve analysis summarizing use of extracardiac anomaly status to screen for genetic disorders. vs. the Test-All and Test-None alternatives. The highest net benefit for using ECA status to screen for high risk of genetic disorders in patients occurs at a risk threshold of ≥14%; however, the Test-All net benefit is higher when the risk threshold is <14%.